Publication | Open Access
Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: A pilot study
91
Citations
35
References
2012
Year
In metastatic breast cancer, metabolomics may play a role in sub selecting patients with HER2 positive disease with greater sensitivity to paclitaxel plus lapatinib.
| Year | Citations | |
|---|---|---|
Page 1
Page 1